Skip to content

Clinical Study of a 3D Shaded Zirconia for Chairside CAD/CAM Restorations

Clinical Study of a 3D Shaded Zirconia for Chairside CAD/CAM Restorations

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06713577
Enrollment
82
Registered
2024-12-03
Start date
2024-12-03
Completion date
2031-11-22
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Prosthesis Complication, Dental Prosthesis Failure

Brief summary

This investigation will be a prospective, longitudinal clinical trial to study the clinical performance of a new monolithic, 3D shaded zirconia material for computer assisted design and computer assisted machining for chairside restorations. The restorations will be evaluated for a period of up to five years. The study is called Clinical Study of a 3D Shaded Zirconia for chairside computer assisted design and computer assisted machining (CAD/CAM) chairside restorations intended to be part of the validation plan and post market follow-up of the following products: CEREC Cercon 4D, Calibra Universal +, and Prime and Bond Active.

Detailed description

The primary aim is: ▪ Evaluate the longitudinal clinical performance of 3D shaded zirconia onlays, crowns, and fixed partial denture (FPD) over five years of clinical service. The restorations will be evaluated with modified FDI criteria for maintaining their esthetic, functional and biological properties. The secondary aims are: * Evaluate the resistance to material chipping and fracture of reduced thickness zirconia chairside computer assisted design and computer assisted machining (CAD/CAM) onlays, crowns, and fixed partial dentures (FPDs). * Evaluate the short-term post-operative sensitivity associated with cementation techniques using a self-adhesive, universal resin cement and a selective etch/universal bonding agent with a universal resin cement.

Interventions

DEVICECEREC Cercon 4D

One investigational medical device is a new generation of a full contour zirconia restorative material (CEREC Cercon 4D/Dentsply Sirona) for chairside computer assisted design/computer assisted machines (CAD/CAM) restorations. It has an internal core of 4 mol% (4Y) zirconia transitioning to an external layer of 4/5 mol% (4/5 Y) zirconia with a three-dimensional gradient of shade from an inner chromatic layer to an external translucent layer that replicates the natural structure and appearance of a tooth. It is indicated for crowns, bridges, veneers, inlays and onlays and implant crowns Clinical Study of a 3D Shaded Zirconia for Chairside CAD/CAM Restorations The other investigational medical devices are a universal bonding agent (Prime and Bond Active/Dentsply Sirona) and dual-cure, self-adhesive resin cement (Calibra Universal +/Dentsply Sirona). They are used in combination to deliver ceramic and zirconia restorations.

Sponsors

Dentsply Sirona Implants and Consumables
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Adult aged 18-75 years. * Willing and able to sign and date the informed consent form and the HIPAA form. * Onlays and Crowns: Each patient should have at least one carious lesion, defective restoration, or fractured portion of the tooth to be restored on a maxillary or mandibular premolar or molar tooth. Each lesion, fracture, or defective restoration should exhibit sufficient size or loss of tooth structure requiring an onlay or crown restoration. The tooth should have at least one opposing tooth in occlusion and one adjacent tooth with an intact proximal contact. No more than eight teeth that are endodontically treated and restorable with an onlay or crown may be included in the study. All remaining teeth in the study will test vital and be asymptomatic at the beginning of treatment. No more than two restorations will be placed per patient. If a patient presents with more than two acceptable teeth for the study, molar teeth will be included prior to premolar teeth. * Fixed Partial Dentures (FPDs): Each patient should have at least one missing tooth, either anterior or posterior, that is appropriate for replacement with a fixed partial denture. Abutment teeth will have healthy periodontal status with at least a 1:1 crown:root ratio. The FPD should have at least two opposing teeth in occlusion and one adjacent tooth with an intact proximal contact. Both abutment teeth must be asymptomatic prior to treatment. Endodontically treated teeth will be acceptable for abutments if nonmetallic cores can be placed to retain the FPD. FPDs may include 3 or 4 teeth as indicated by the clinical situation but must be within the 43 mm span of the mill block to manufacture it as described later. The patient cohort should include a mix of non-endodontically as well as endodontically treated teeth.

Exclusion criteria

* Unlikely to be able to comply with clinical study procedures, according to Principal Investigator's (PIs) judgment. * Subject is not willing to participate in the clinical study. * Patients unable to return for the recall appointments for a period of 5 years. * Severe non-compliance to the clinical study plan as judged by the PI and/or Dentsply Sirona. * Involvement in the planning and conduct of the clinical study. Applies to both Dentsply Sirona personnel and personnel from the clinical study site. * Sensitive teeth. * Teeth diagnosed with symptoms of incomplete tooth fracture. * Teeth with a history of direct or indirect pulp capping procedures. * Patients with significant untreated dental disease to include periodontitis and/or rampant caries. * Women who self-report that they are possibly pregnant, pregnant, or lactating, as elective dental treatment is not indicated at these times. * Patients with a self-reported history of allergies to the materials to be used in the study including composite resin cements, provisional acrylics, or zirconia restorative materials.

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of the longitudinal clinical performance of 3D shaded zirconia onlays, crowns and FPDs.At the five year follow upThe restorations will be evaluated according to the modified World Dental Federation notation (FDI) criteria for maintaining their esthetic functional and biological properties.

Secondary

MeasureTime frameDescription
Evaluation of the longitudinal clinical performance of 3D shaded zirconia onlays, crowns and FPDs.At the 6 month, 1 year, 2 year, 3 year and 4 year follow upThe restorations will be evaluated according to the modified World Dental Federation notation criteria (FDI) for maintaining their esthetic functional and biological properties.
Evaluation of the resistance of the material chipping and fracture of the reduce thickness zirconia CAD/CAM onlays, crowns and FPDs.At the 6 month, 1 year, 2 year, 3 year and 4 year and 5 year follow up.The restorations will be evaluated according to the modified World Dental Federation notation (FDI) criteria for maintaining their esthetic functional and biological properties.
Evaluation of the short-term post operative sensitivity associated with cementation techniques using a self-adhesive, universal resin cement and a selective etch/universal bonding agent with a universal resin cement.Once a week after base line up to four weeks or until patient is asymptomatic.A criterion-referenced rating scale will be used to measure sensitivity (Scores 1-4) Sensitivity: 1. = No sensitivity is experienced at anytime 2. = Slight sensitivity is experienced occasionally but it is not uncomfortable 3. = Moderate sensitivity is experienced intermittently, and it is noticeably uncomfortable 4. = Severe discomfort is noted routinely with cold or pressure stimulation

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORDennis J Fasbinder

Clinical Professor of Dentistry, Department of Cardiology, Restorative Sciences, and Endodontics

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026